Abdul MM, Kazi FA, Zainal MD, Abdul MD (2006). Determination and characterization of caffeine in tea, coffee and soft drinks by solid phase extraction and high performance liquid chromatography (SPE-HPLC), Malaysian J. Chem. 8:45-51.

Altun ML (2002). HPLC method for the analysis of paracetamol, caffeine and dipyrone, Turk. J. Chem. 26(4):521-528.

Burge LJ, Raches DW (2003). Determination of caffeine by HPLC with UV detector, J. Liquid Chromatogr. Related Technol. 26:1977-1990.
Crossref

Butt MS, Sultan MT (2011). Coffee and its consumption: Benefits and risks. Crit. Rev. Food Sci. Nutr. 51:363-373.
Crossref

European Food Safety Authority (EFSA) (2015). Scientific Opinion on the safety of caffeine. EFSA J. 13(5):4102. Available at: 

View

Evans JC (1992). Tea in China: The History of China's National Drink. Greenwood Press. P 2.

Franeta JT, Agbaba D, Eric S, Pavkov S, Aleksic M, Vladimirov S (2002). Aleksic M, and Vladimirov S, HPLC assay of acetylsalicylic acid, paracetamol, caffeine and phenobarbital in tablets. Farmaco 57(9):709-713.
Crossref

Guercio BJ, Sato K, Niedzwiecki D, Ye X, Saltz LB, Mayer RJ, Mowat RB, Whittom R, Hantel A, Benson A, Atienza D (2015). Coffee Intake, Recurrence, and Mortality in Stage III Colon Cancer: Results From CALGB 89803 (alliance). J. Clin. Oncol. 33(31):3598-3607.
Crossref

Guidance for Industry on Bioanalytical Method Validation (2011). D.o.H.a.H.S. Center for Drug Evaluation and Research (CDER), Editor 2001, US Food and Drug Administration: Rockville, MD. Available at: 

View

Khalaf N, White D, Kanwal F, Ramsey D, Mittal S, Tavakoli-Tabasi S, Kuzniarek J, El-Serag HB (2015). Coffee and Caffeine Are Associated With Decreased Risk of Advanced Hepatic Fibrosis Among Patients With Hepatitis C. Clin. Gastroenterol. Hepatol. 13:1521-1531.
Crossref

Liu F, Wang X, Wu G, Chen L, Hu P, Ren H, Hu H (2015). Coffee consumption decreases risks for hepatic fibrosis and cirrhosis: a meta-analysis. PloS one, 10(11):e0142457.
Crossref57

Natarajan G, Lulic-Botica M, Thomas R, Aranda JV (2007). Therapeutic drug monitoring for caffeine in preterm infants: An unnecessary exercise? Pediatrics. 119:936-940.
Crossref

Nordestgaard AT, Thomsen M, Nordestgaard BG (2015). Coffee intake and risk of obesity, metabolic syndrome and type 2 diabetes: A Mendelian randomization study. Int. J. Epidemiol. 44(2):551-565.
Crossref

Prediger RD (2010). Effects of caffeine in Parkinson's disease: from neuroprotection to the management of motor and non-motor symptoms, J. Alzheimer's Dis. 20(s1):S205-S220.
Crossref

Ramos-Martos N, Aguirre-Gomez F, Molinz-Diaz A, Capitan-Vallvey LF (2001). Application of liquid chromatography to the simultaneous determination of acetylsalicylic acid, caffeine, codeine, paracetamol, pyridoxine, and thiamine in pharmaceutical preparations. J. AOAC Int. 84(3):676-683.

Rezk NL, White NR, Jennings SH, Kashuba AD (2009). A novel LC-ESI-MS method for the simultaneous determination of etravirine, darunavir and ritonavir in human blood plasma. Talanta 79(5):1372-1378.
Crossref

Sawyer M, Kumar V (2003). A rapid high-performance liquid chromatographic method for the simultaneous quantitation of aspirin, salicylic acid, and caffeine in effervescent tablets. J. Chromatogr. Sci. 41(8):393-397.
Crossref

Stovner L, Zwart J, Hagen K, Terwindt G, Pascual J (2006). Epidemiology of headache in Europe, Eur. J. Neurol. 13:333-345.
Crossref

Violeta N, Ion T, Mira EI (2010). Chromatographic determination of caffeine contents in soft and energy drinks available on the Romanian, St. Cerc. St. CICBIA 11:351-358.

Violetaa N, Trandafir I, Elenaa IM (2008). Quantitative determination of caffeine in carbonated beverages by an HPLC method. J. Agroaliment. Proc. Technol. 14:123-127.

Weinberg BA, Bealer BK (2001). The World of Caffeine: The Science and Culture of the World's Most Popular Drug. Routledge. pp. 3-4.

Yu L (1995). The Classic of Tea: Origins & Rituals. Ecco Press. 416.